iSpecimen Inc. (ISPC): Price and Financial Metrics

iSpecimen Inc. (ISPC): $1.25

-0.01 (-0.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ISPC Price/Volume Stats

Current price $1.25 52-week high $3.26
Prev. close $1.26 52-week low $1.17
Day low $1.22 Volume 39,000
Day high $1.30 Avg. volume 26,040
50-day MA $1.45 Dividend yield N/A
200-day MA $1.62 Market Cap 11.29M

ISPC Stock Price Chart Interactive Chart >

ISPC Stock Summary

  • ISPC has a higher market value than only 5.35% of US stocks; more precisely, its current market capitalization is $12,370,237.
  • The ratio of debt to operating expenses for ISPECIMEN INC is higher than it is for about merely 4.81% of US stocks.
  • With a year-over-year growth in debt of -96.04%, ISPECIMEN INC's debt growth rate surpasses just 1% of about US stocks.
  • Stocks that are quantitatively similar to ISPC, based on their financial statements, market capitalization, and price volatility, are OPK, TOUR, UEIC, MIND, and CARS.
  • Visit ISPC's SEC page to see the company's official filings. To visit the company's web site, go to ispecimen.com.

ISPC Valuation Summary

  • ISPC's EV/EBIT ratio is -0.9; this is 107.5% lower than that of the median Healthcare stock.
  • Over the past 24 months, ISPC's price/sales ratio has gone down 4.2.

Below are key valuation metrics over time for ISPC.

Stock Date P/S P/B P/E EV/EBIT
ISPC 2023-05-23 1.2 0.7 -1.2 -0.9
ISPC 2023-05-22 1.1 0.6 -1.1 -0.8
ISPC 2023-05-19 1.1 0.6 -1.1 -0.8
ISPC 2023-05-18 1.2 0.7 -1.2 -0.9
ISPC 2023-05-17 1.2 0.7 -1.3 -0.9
ISPC 2023-05-16 1.2 0.7 -1.3 -1.0

iSpecimen Inc. (ISPC) Company Bio


iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.


ISPC Latest News Stream


Event/Time News Detail
Loading, please wait...

ISPC Latest Social Stream


Loading social stream, please wait...

View Full ISPC Social Stream

Latest ISPC News From Around the Web

Below are the latest news stories about ISPECIMEN INC that investors may wish to consider to help them evaluate ISPC as an investment opportunity.

iSpecimen Reports First Quarter 2023 Results

Quarterly Revenue Increased 17% Year-Over-YearLEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended March 31, 2023. “I am pleased to report that iSpecimen delivered strong revenue of approximately $3.0 million,

Yahoo | May 4, 2023

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023. Ms. Curley will present on Thursday, May 4, 2023, at 4:30 p.m. ET. To attend, please join here. For more

Yahoo | April 24, 2023

iSpecimen to Report First Quarter 2023 Results on May 4, 2023

LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market opens on Thursday, May 4, 2023. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Ea

Yahoo | April 20, 2023

Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost

iSpecimen Inc. ( NASDAQ:ISPC ) shares have had a really impressive month, gaining 33% after a shaky period beforehand...

Yahoo | April 18, 2023

iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript March 14, 2023 Operator: Good day, everyone and welcome to iSpecimen’s Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode. A question-and-answer session will follow managements’ remarks. This conference call is being recorded. A replay of today’s call will be available […]

Yahoo | March 17, 2023

Read More 'ISPC' Stories Here

ISPC Price Returns

1-mo -19.44%
3-mo -23.31%
6-mo -20.38%
1-year -59.55%
3-year N/A
5-year N/A
YTD -9.09%
2022 -82.39%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6869 seconds.